Who Owns CorMedix Stock?
NASDAQ: CRMDHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 57.81%
- Held by insiders
- 7.61%
- Institutional holders
- 261
- Institutions 57.8%
- Insiders 7.6%
- Public and other 34.6%
Who owns CorMedix stock?
Institutional investors own about 57.8% of CorMedix's shares, spread across 261 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 7.61% of CRMD.
The largest institutional holders are Blackrock Inc. (8.11%), Deep Track Capital, Lp (8.05%) and Vanguard Capital Management LLC (4.02%). Together, the top 10 institutions control 34.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their CRMD positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CRMD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 6.32M | 8.11% | +6.0% |
| Deep Track Capital, Lp | 6.27M | 8.05% | 0.0% |
| Vanguard Capital Management LLC | 3.14M | 4.02% | +0.2% |
| State Street Corporation | 2.32M | 2.97% | +5.7% |
| Royce & Associates LP | 2.18M | 2.79% | +15.3% |
| Geode Capital Management, LLC | 1.95M | 2.50% | +7.2% |
| UBS Group AG | 1.88M | 2.41% | +22.1% |
| Oberweis Asset Management Inc. | 1.32M | 1.70% | +9.3% |
| Alyeska Investment Group, L.p. | 850.00K | 1.09% | 0.0% |
| Marshall Wace LLP | 779.53K | 1.00% | +55.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CRMD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.23M | 2.86% |
| iShares Trust-iShares Russell 2000 ETF | 1.91M | 2.45% |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 1.58M | 2.02% |
| OBERWEIS FUNDS-Oberweis Micro-Cap Fund | 1.28M | 1.64% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 824.08K | 1.06% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 816.50K | 1.05% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 748.99K | 0.96% |
| iShares Trust-iShares Russell 2000 Value ETF | 695.91K | 0.89% |
| Pacer Funds Trust-Pacer US Small Cap Cash Cows 100 ETF | 626.12K | 0.80% |
| ROYCE FUND-Royce Small-Cap Opportunity Fund | 566.90K | 0.73% |
Frequently asked questions
Who is the largest shareholder of CorMedix?
Blackrock Inc. is the largest institutional shareholder of CRMD, owning 8.11% of shares outstanding (6.32M shares) as of its latest 13F filing.
What percentage of CorMedix is owned by institutions?
Institutions own about 57.8% of CRMD shares and 62.6% of the public float.
How much of CorMedix do insiders own?
Insiders, such as officers and directors, own about 7.61% of CRMD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.